Search research articles
Contact Us
Filters
Showing results (21-30 of 148) with videos related to
Page
of 15
Sort By:
The Journal of Infectious Diseases
|
April 4, 2002
A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy
Judith A Aberg, Richard W Price, Dorie M Heeren, et al.
Journal of Neurochemistry
|
June 25, 2021
Neurochemical biomarkers to study CNS effects of COVID-19: A narrative review and synthesis
Arvid Edén, Joel Simrén, Richard W Price, et al.
Acta Neurologica Scandinavica
|
April 26, 2022
Blood biomarkers for HIV infection with focus on neurologic complications-A review
Lars Hagberg, Arvid Edén, Henrik Zetterberg, et al.
Plos One
|
July 23, 2020
Herpes zoster in HIV-1 infection: The role of CSF pleocytosis in secondary CSF escape and discordance
Lars Hagberg, Richard W Price, Henrik Zetterberg, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
March 7, 2017
Greater Risk of Stroke of Undetermined Etiology in a Contemporary HIV-Infected Cohort Compared with Uninfected Individuals
Felicia C Chow, Richard W Price, Priscilla Y Hsue, et al.
Handbook of Clinical Neurology
|
September 24, 2008
Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex
Paola Cinque, Bruce J Brew, Magnus Gisslen, et al.
AIDS Research and Therapy
|
August 20, 2005
Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection
Magnus Gisslén, Lars Rosengren, Lars Hagberg, et al.
The Lancet. HIV
|
September 23, 2022
A new approach to cognitive impairment in people with HIV
Sam Nightingale, Paola Cinque, John A Joska, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
September 6, 2008
OTK18 levels in plasma and cerebrospinal fluid correlate with viral load and CD8 T-cells in normal and AIDS patients
James L Buescher, Fenghai Duan, Junfeng Sun, et al.
The Journal of Infectious Diseases
|
November 17, 2006
Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure
Serena Spudich, Nicole Lollo, Teri Liegler, et al.
Page
of 15
Search research articles
Search
Showing results (21-30 of 148) with videos related to
Sort By:
Page
of 15
The Journal of Infectious Diseases
|
April 4, 2002
A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy
Judith A Aberg, Richard W Price, Dorie M Heeren, et al.
Journal of Neurochemistry
|
June 25, 2021
Neurochemical biomarkers to study CNS effects of COVID-19: A narrative review and synthesis
Arvid Edén, Joel Simrén, Richard W Price, et al.
Acta Neurologica Scandinavica
|
April 26, 2022
Blood biomarkers for HIV infection with focus on neurologic complications-A review
Lars Hagberg, Arvid Edén, Henrik Zetterberg, et al.
Plos One
|
July 23, 2020
Herpes zoster in HIV-1 infection: The role of CSF pleocytosis in secondary CSF escape and discordance
Lars Hagberg, Richard W Price, Henrik Zetterberg, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
March 7, 2017
Greater Risk of Stroke of Undetermined Etiology in a Contemporary HIV-Infected Cohort Compared with Uninfected Individuals
Felicia C Chow, Richard W Price, Priscilla Y Hsue, et al.
Handbook of Clinical Neurology
|
September 24, 2008
Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex
Paola Cinque, Bruce J Brew, Magnus Gisslen, et al.
AIDS Research and Therapy
|
August 20, 2005
Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection
Magnus Gisslén, Lars Rosengren, Lars Hagberg, et al.
The Lancet. HIV
|
September 23, 2022
A new approach to cognitive impairment in people with HIV
Sam Nightingale, Paola Cinque, John A Joska, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
September 6, 2008
OTK18 levels in plasma and cerebrospinal fluid correlate with viral load and CD8 T-cells in normal and AIDS patients
James L Buescher, Fenghai Duan, Junfeng Sun, et al.
The Journal of Infectious Diseases
|
November 17, 2006
Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure
Serena Spudich, Nicole Lollo, Teri Liegler, et al.
Page
of 15